BioSpace News Archive

Occlutech Holding AG, a leading specialist provider of minimally invasive structural heart disease devices, addressing congenital heart defects, stroke prevention and heart failure, has successfully completed a private placement of shares of 450 MSEK before transaction costs, to the Fourth Swedish National Pension Fund, Carnegie Private Banking and certain other investors.

CStone Pharmaceuticals is pleased to announce that the National Medical Products Administration of China has approved the new drug application of anti-PD-L1 monoclonal antibody Cejemly® in combination with chemotherapy for treatment-naïve metastatic non-small cell lung cancer patients.

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, and the Australian Nuclear Science and Technology Organisation, a public research organization and international leader in the field of nuclear science and technology, announced the extension of their partnership by entering into a further long-term licensing agreement.

BioRestorative Therapies, Inc. today announced its Chief Executive Officer, Lance Alstodt, will be featured on the James Hicks “NewMedia Show” on Tuesday, December 21st.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of privately held Scanwell Health Inc., a leader in smartphone-enabled at-home medical tests.

To Assist Employers, Consultants Available to Design Testing Programs to Meet OSHA Deadline; Antigen and PCR Tests Available.

Henry Schein, Inc. (Nasdaq: HSIC) today announced that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of the Company, was honored by The National Hispanic Foundation (NHHF) for his leadership in helping to improve health equity and supporting the needs of Hispanic communities and health professionals.

NovaBay ® Pharmaceuticals, Inc. announces that its Special Meeting of Stockholders held on December 17, 2021 has been adjourned until January 14, 2022 at 11:00 a.m. Pacific time.

FDA informs Sol-Gel that it intends to conduct a pre-approval inspection of the production site for EPSOLAY during the week of February 14th, 2022.

Schrödinger today announced that Joel Lebowitz is retiring from his position as chief financial officer.